Hep C Treatment Barriers for Rural Aboriginal South Australians

The rate of hepatitis C infections in Aboriginal and Torres Strait Islander communities in Australia is increasing even as infection rate decreases in the wider community. This is despite the introduction of direct-acting antiviral (DAA) drugs that offer the chance to completely eliminate the hepatitis C virus (HCV).

Continue reading “Hep C Treatment Barriers for Rural Aboriginal South Australians”

Creating a Hep C Home Test—with AI

Going beyond pregnancy and COVID-19, the world could someday soon come to rely on at-home tests for many diseases thanks in part to AI-fuelled improvements. University of Florida (UF) scientists have used artificial intelligence tools to simplify a test that works for both hepatitis C and SARS-CoV-2, the virus that causes COVID-19. The simplified test happens in one small test tube in just a few minutes. With further refinement, it could come to doctor’s offices soon and, one day, even home tests that are as easy as a pregnancy test.

Continue reading “Creating a Hep C Home Test—with AI”

DAA Treatment for Children

Chronic hepatitis C virus (HCV) infection affects around 3.5 million children worldwide, and in Australia, it’s estimated that it affects at least 4 children per million under 15 years old. Children with chronic hepatitis C infection can suffer from reduced quality of life, social stigmatisation, and inadequate access to specialist care. As with adults, the disease can progress to hepatic fibrosis, chronic liver disease, and hepatocellular cancer.

Continue reading “DAA Treatment for Children”

10 Ways to Reduce Blood-Borne Viruses in Prisons

Clean needle program tops the list of strategies outlined in a consensus statement released by the Harm Reduction in Prisons Working Group. The statement aims to provide a clear, concise overview of evidence-based harm reduction interventions needed to reduce injecting-related harms in Australian prisons.

Continue reading “10 Ways to Reduce Blood-Borne Viruses in Prisons”

Eliminating Mother-to-Baby Hep B Transmission?

Mother-to-child transmission of hepatitis B occurs frequently either in the uterus, through placental leakage, or through exposure to blood or blood-contaminated fluids at or around the time of birth. This form of transmission (sometimes called “vertical transmission”) is believed to account for between a third and a half of hepatitis B infections, and so a way to easily prevent it would do a huge amount to reduce the number of people living with hepatitis B in the long term.

Continue reading “Eliminating Mother-to-Baby Hep B Transmission?”